• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Par Drugs and Chemicals Limited — Board Meeting, 13-11-2025: Outcome of Board Meeting

    13-11-2025 | 04:41 pm

    Par Drugs & Chemicals' board approved Q2 & H1 FY26 financial results. Q2 revenue hit ₹28.66 Cr with net profit of ₹4.13 Cr. H1 revenue reached ₹54.71 Cr, net profit ₹7.46 Cr.

    No comments yet. Be the first to comment!

    All announcements from Par Drugs and Chemicals Limited